Male Infertility Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The Male Infertility Market is segmented By Test Type (Sperm Agglutination, DNA Fragmentation Technique, Oxidative Stress Analysis, Computer Assisted Semen Analysis, Sperm Penetration Assay), By Treatment, and Geography.

Male Infertility Market Snapshot

male infertility market
Study Period: 2018 - 2026
Base Year: 2020
Fastest Growing Market: Asia Pacific
Largest Market: Europe
CAGR: 5.41 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The Male Infertility Market is expected to register a CAGR of 7.5% during the forecast period. This is attributing to the increasing incidence of infertility, high adoption of assisted reproductive technology (ART), technological advancement. According to the National Institute of Health (NIH), a report published in 2019, said that 8% to 10% of couples globally are affected by infertility making it a serious health issue. Assisted reproductive technology is a medical procedure used to treat infertility. It also offers a quick fix to the male facing problems in infertility due to abnormal sperm quality, low sperm count and poor motility and being widely adopted due to its benefits like higher success rate compared to medications. Thus, increasing population with infertility coupled with technological advancements in the field of assisted reproductive technologies results in promoting the revenue growth of male infertility market. Moreover, rising stress levels, obesity, smoking, consumption of alcohols is also some of the factors that are contributing to infertility in male. Furthermore, growing awareness, increasing R&D expenditure and changing lifestyle are also fueling the male infertility market

Scope of the Report

As per the scope, Male infertility is a type of health issue which lowers the chances of his female partner getting pregnant. It is majorly caused due to hormonal problems, low sperm count and presence of a low number of motile sperms. Male Infertility Market is segmented By Test Type, Treatment and Geography.

By Test Type
Sperm Agglutination
DNA Fragmentation Technique
Oxidative Stress Analysis
Computer Assisted Semen Analysis
Sperm Penetration Assay
Others
By Treatment
Medication
Assisted Reproductive Technology and Varicocele Surgery
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

DNA Fragmentation in Male Infertility Market is Estimated to Witness a Healthy Growth in Future.

DNA Fragmentation technique is estimated to witness a healthy growth in the future attributed to high adoption and ability of the diagnostic procedures to offer a reliable analysis of sperm DNA integrity. As DNA fragmentation in sperm is one of the main factors which affects male infertility. This technique used for diagnosis purposes in determining male infertility.

Moreover, Computer-assisted semen analysis is also going to witness a healthy growth owing to technological advancements associated with a semen analysis. For instance, Sandstone Diagnostics received approval for Trak Volume Cup from the United States Food and Drug Administration (US FDA) in 2018, this device is used to diagnose hyposperia and measure semen volume. This technique is most preferred for diagnosis due to rapid quantitative assessments and can be performed through microscopes. Thus benefits associated with these techniques results in promoting segment growth

Male Infertility Market

To understand key trends, Download Sample Report

Europe is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

Europe expected to hold a significant market share in the global Male Infertility Market due to the high adoption of costlier treatments, availability of well equipped and advanced fertility clinics, high awareness level and openness among the population towards disorders. Moreover, healthcare expenditure and the presence of well-established healthcare infrastructure are also fueling the growth of the overall regional market to a large extent.

Male Infertility Market

To understand geography trends, Download Sample Report

Competitive Landscape

The Male Infertility Market is fragmented competitive and consists of several major players. Some of the companies which are currently dominating the market are Halotech DNA, Bayer AG, EMD Serono Inc., Endo International plc, Vitrolife, Theramex, Aytu BioScience, Sandstone Diagnostics, Inc., and CinnaGen Co.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing incidence of infertility

      2. 4.2.2 High Adoption of Assisted Reproductive Technology (ART)

      3. 4.2.3 Technological Advancements

    3. 4.3 Market Restraints

      1. 4.3.1 High Cost of Treatment

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Test Type

      1. 5.1.1 Sperm Agglutination

      2. 5.1.2 DNA Fragmentation Technique

      3. 5.1.3 Oxidative Stress Analysis

      4. 5.1.4 Computer Assisted Semen Analysis

      5. 5.1.5 Sperm Penetration Assay

      6. 5.1.6 Others

    2. 5.2 By Treatment

      1. 5.2.1 Medication

      2. 5.2.2 Assisted Reproductive Technology and Varicocele Surgery

    3. 5.3 Geography

      1. 5.3.1 North America

        1. 5.3.1.1 United States

        2. 5.3.1.2 Canada

        3. 5.3.1.3 Mexico

      2. 5.3.2 Europe

        1. 5.3.2.1 Germany

        2. 5.3.2.2 United Kingdom

        3. 5.3.2.3 France

        4. 5.3.2.4 Italy

        5. 5.3.2.5 Spain

        6. 5.3.2.6 Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. 5.3.3.1 China

        2. 5.3.3.2 Japan

        3. 5.3.3.3 India

        4. 5.3.3.4 Australia

        5. 5.3.3.5 South Korea

        6. 5.3.3.6 Rest of Asia-Pacific

      4. 5.3.4 Middle-East and Africa

        1. 5.3.4.1 GCC

        2. 5.3.4.2 South Africa

        3. 5.3.4.3 Rest of Middle-East and Africa

      5. 5.3.5 South America

        1. 5.3.5.1 Brazil

        2. 5.3.5.2 Argentina

        3. 5.3.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Halotech DNA

      2. 6.1.2 Bayer AG

      3. 6.1.3 Merck KGaA (EMD Serono Inc.)

      4. 6.1.4 Endo International plc.

      5. 6.1.5 Vitrolife

      6. 6.1.6 Theramex

      7. 6.1.7 Aytu BioScience

      8. 6.1.8 Sandstone Diagnostics, Inc.

      9. 6.1.9 CinnaGen Co.

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Male Infertility Market market is studied from 2018 - 2026.

The Male Infertility Market is growing at a CAGR of 5.41% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

Europe holds highest share in 2020.

Halotech DNA, Bayer AG, Endo International plc, Vitrolife, Merck KGaA are the major companies operating in Male Infertility Market .

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!